• 1
    Skuk D, Roy B, Goulet M et al.Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 2004; 9: 475482.
  • 2
    Skuk D, Furling D, Bouchard JP et al. Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophy. J Neuropathol Exp Neurol 1999; 58: 921931.
  • 3
    Chachques JC, Cattadori B, Herreros J et al. Treatment of heart failure with autologous skeletal myoblasts. Herz 2002; 27: 570578.
  • 4
    Skuk D, Tremblay JP. Complement deposition and cell death after myoblast transplantation. Cell Transplant 1998; 7: 427434.
  • 5
    Maurel A, Azarnoush K, Sabbah L et al. Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation 2005; 80: 660665.
  • 6
    Zhan M, Zhao H, Han ZC. Signalling mechanisms of anoikis. Histol Histopathol 2004; 19: 973983.
  • 7
    Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619626.
  • 8
    Fukai F, Mashimo M, Akiyama K et al. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp Cell Res 1998; 242: 9299.
  • 9
    Haake AR, Polakowska RR. Cell death by apoptosis in epidermal biology. J Invest Dermatol 1993; 101: 107112.
  • 10
    Bonfoco E, Chen W, Paul R et al. beta1 integrin antagonism on adherent, differentiated human neuroblastoma cells triggers an apoptotic signaling pathway. Neuroscience 2000; 101:11451152.
  • 11
    Thomas FT, Contreras JL, Bilbao G et al. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery 1999; 126: 299304.
  • 12
    Schlaepfer DD, Hanks SK, Hunter T et al. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994; 372: 786791.
  • 13
    Kennedy SG, Wagner AJ, Conzen SD et al.The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 1997; 11: 701713.
  • 14
    Li B, Desai SA, MacCorkle-Chosnek RA et al. A novel conditional Akt ‘survival switch’ reversibly protects cells from apoptosis. Gene Ther 2002; 9: 233244.
  • 15
    Grossmann J. Molecular mechanisms of "detachment-induced apoptosis–Anoikis". Apoptosis 2002; 7: 247260.
  • 16
    Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996; 134: 793799.
  • 17
    Rytomaa M, Martins LM, Downward J. Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis. Curr Biol 1999; 9: 10431046.
  • 18
    Jan Y, Matter M, Pai JT et al. A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell 2004; 116: 751762.
  • 19
    Blaschuk KL, Guerin C, Holland PC. Myoblast alpha v beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation. Dev Biol 1997; 184: 266277.
  • 20
    Lan MA, Gersbach CA, Michael KE et al Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries. Biomaterials 2005; 26: 45234531.
  • 21
    Sastry SK, Lakonishok M, Thomas DA et al. Integrin alpha subunit ratios, cytoplasmic domains, and growth factor synergy regulate muscle proliferation and differentiation. J Cell Biol 1996; 133: 169184.
  • 22
    Gullberg D, Sjoberg G, Velling T et al. Analysis of fibronectin and vitronectin receptors on human fetal skeletal muscle cells upon differentiation. Exp Cell Res 1995; 220: 112123.
  • 23
    Clyman RI, Mauray F, Kramer RH. Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res 1992; 200: 272284.
  • 24
    Steffensen B, Magnuson VL, Potempa CL et al. Alpha 5 integrin subunit expression changes during myogenesis. Biochim Biophys Acta 1992; 1137: 95100.
  • 25
    Meredith JE Jr., Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993; 4: 953961.
  • 26
    Bouchentouf M, Benabdallah BF, Tremblay JP. Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 2004; 77: 13491356.
  • 27
    Grambihler A, Higuchi H, Bronk SF et al. cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis. J Biol Chem 2003; 278: 2683126837.
  • 28
    Stewart CE, Rotwein P. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 1996; 271: 1133011338.
  • 29
    Barbero A, Benelli R, Minghelli S et al. Growth factor supplemented matrigel improves ectopic skeletal muscle formation–a cell therapy approach. J Cell Physiol 2001; 186: 183192.
  • 30
    Skuk D, Goulet M, Roy B et al. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp Neurol 2002; 175: 112126.
  • 31
    Menasche P, Hagege AA, Scorsin M et al.Myoblast transplantation for heart failure. Lancet 2001; 357: 279280.
  • 32
    Matter ML, Ruoslahti E. A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription. J Biol Chem 2001; 276: 2775727763.
  • 33
    Zlender V. [Apoptosis–programmed cell death]. Arh Hig Rada Toksikol 2003; 54: 267274.
  • 34
    Derradji H, Baatout S. Apoptosis: A mechanism of cell suicide. In Vivo 2003; 17: 185192.
  • 35
    Skuk D, Caron NJ, Goulet M et al. Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol 2003; 62: 951967.